tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO

Halozyme (HALO) Revenue

Compare
1,023 Followers

Halozyme Revenue

Halozyme had a revenue of 264.86M in the quarter ending Mar 31, 2025, with -11.12%. This bring the company's revenue in the last twelve months to 1.08B, Decreased 6.79%. In the fiscal year ending Dec 31, 2024, Halozyme had annual revenue of 1.02B with 22.44% growth.
Revenue (ttm)
1.08B
Revenue Growth
25.65%
P/S Ratio
6.58
Revenue/Employee
$2,900,926
Employees
350
Market Cap
$6.68B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.02B186.07M+22.44%
Dec 31, 2023
829.25M169.14M+25.62%
Dec 31, 2022
660.12M216.81M+48.91%
Dec 31, 2021
443.31M175.72M+65.67%
Dec 31, 2020
267.59M71.60M+36.53%
Dec 31, 2019
195.99M44.13M+29.06%
Dec 31, 2018
151.86M-164.75M-52.04%
Dec 31, 2017
316.61M169.92M+115.84%
Dec 31, 2016
146.69M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis